• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    12.63 Up 0.08(0.64%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 50,157   33,879   32,727  
    Cost of Revenue1,583   -  129  
    Gross Profit 48,574   33,879   32,598  
    Operating Expenses
    Research Development19,230  28,502  45,764  
    Selling General and Administrative84,644  25,082  14,517  
    Non Recurring -   -   -  
    Others2,254  1,495  1,495  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 20,062   (21,200) (29,178)
    Income from Continuing Operations
    Total Other Income/Expenses Net77,740  145  561  
    Earnings Before Interest And Taxes97,802  (21,055)(28,617)
    Interest Expense -   -   -  
    Income Before Tax97,802  (21,055)(28,617)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops97,802  (21,055)(28,617)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 20,186   (21,055) (28,617)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 20,186   (21,055) (28,617)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.